# Georgia Diabetes Translation Research Center

> **NIH NIH P30** · EMORY UNIVERSITY · 2020 · $480,605

## Abstract

PROJECT SUMMARY/ABSTRACT
The diabetes epidemic in the United States (US) has evolved considerably over the last quarter century. Of note,
the growth in prevalence and absolute numbers of people with diabetes has far exceeded statistical projections,
growing proportions of those affected by diabetes are people of minority race/ethnicities and from lower
socioeconomic backgrounds, and onset and first diagnosis appear to be younger than in decades past. Though
the evidence base for diabetes prevention and management has grown ‒ and with that, some improvement in
care and control of diabetes and associated co-morbidities ‒ major gaps persist: 1) The proportion of people with
undiagnosed diabetes and prediabetes has not improved; 2) Engagement in prevention is exceedingly low; and
3) Young adults and disenfranchised populations with diabetes fare poorly in terms of control. And, while
incidence rates of “classical” diabetes complications like myocardial infarction, stroke, and amputations have
dramatically declined in the last 20 years, again, these declines were less impressive for young adults, minorities,
and low socioeconomic populations; and there have been increases in other diabetes complications like cognitive
decline, depression, and heart failure. As such, it appears that younger people with diabetes will contend with
classical complications earlier in life and older Americans with diabetes will contend with more years of physical
and mental disability. This has profound implications for US health care in terms of the volume, complexity (i.e.,
multi-morbidity) of cases, and health system costs related to diabetes. To address these trends in the
Southeastern US, where disparities in diabetes outcomes are particularly apparent, Emory University, Georgia
Institute of Technology, and the Morehouse School of Medicine together propose to establish the Georgia
Diabetes Translation Research Center (GDTRC). With its broad base of expertise; wealth of federal- and
foundation-funded project platforms; access to communities, health systems, local and federal government; and
readily-available tools and technologies; the GDTRC is poised to accelerate the conduct and use of diabetes
translation research in the Southeast. The GDTRC offers Translation Research Cores (Design and Evaluation;
Engagement and Behavior Change; and Disparities) designed to be responsive to the need to close remaining
gaps in diabetes detection, prevention, and care, and to the changing profile of the US diabetes population.
GDTRC will bring a spirit of innovation, collegiality, multidisciplinarity, inclusivity (e.g., considering disparities from
traditional [race/ethnic] and new perspectives [e.g., disparities across the lifespan; disparate outcomes in people
with depression or cognitive decline]), and continued learning towards promoting more and useful diabetes
translation research. Further, the GDTRC's Regional Core, Enrichment Program, and Pilot and Feasibility
Program will “gr...

## Key facts

- **NIH application ID:** 10007793
- **Project number:** 5P30DK111024-05
- **Recipient organization:** EMORY UNIVERSITY
- **Principal Investigator:** Kabayam M Venkat Narayan
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $480,605
- **Award type:** 5
- **Project period:** 2016-09-16 → 2021-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10007793

## Citation

> US National Institutes of Health, RePORTER application 10007793, Georgia Diabetes Translation Research Center (5P30DK111024-05). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10007793. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*